SC
IMA

Steven Cohen’s ImageneBio Inc IMA Stock Holding History

Steven Cohen’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-111,958
Closed -$4.77M – 1644
2022
Q3 		$4.77M Buy
111,958
+54,567
+95% +$3.16M 0.02% 738
2022
Q2 		$3.05M Buy
57,391
+28,333
+98% +$1.56M 0.01% 831
2022
Q1 		$2.13M Buy
+29,058
New +$3.09M 0.01% 866

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steven Cohen's IMA Position: Q4 2022 in Review

Steven Cohen sold out of ImageneBio Inc (IMA) in Q4 2022, closing a stake of 111,958 shares — an estimated $4.77M sold.

Steven Cohen first reported a position in IMA in Q1 2022 and held it in 3 quarters. The position peaked at $4.77M in Q3 2022. 34 funds tracked by Wall St. Rank hold IMA as of Q4 2022.

  • Steven Cohen reported no remaining ImageneBio Inc position as of Q4 2022 after selling out during the quarter.
  • Steven Cohen sold 111,958 ImageneBio Inc shares in Q4 2022, an estimated $4.77M.
  • Steven Cohen first reported a position in ImageneBio Inc in Q1 2022 and held it in 3 quarters.
  • Steven Cohen's ImageneBio Inc position peaked at $4.77M in Q3 2022.
  • 34 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2022.

Based on Point72 Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.